Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin in blepharospasm with shortened injection intervals
NCT00507637Phase 2Terminated
- Sponsor
- Merz
- Start
- Aug 2007
- Primary completion
- Feb 2008
- Countries
- 1
01
Overview
A Phase 2 trial of incobotulinumtoxinA in benign essential blepharospasm (BEB), sponsored by Merz. Started Aug 2007; status: terminated.
02
Drugs
incobotulinumtoxinA
03
Conditions
benign essential blepharospasm (BEB)
Beyond the preview
Go deeper on NCT00507637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00507637.